ClinicalTrials.gg
CompletedNCT07312617Updated Jan 8, 2026

Short-Term Outcomes of TOT, TVT, and Burch Surgery Assessed by Transperineal Ultrasound

An interventional study of Transobturator Tape (TOT) Procedure and Tension-Free Vaginal Tape (TVT) Procedure in Stress Urinary Incontinence in Women and Pelvic Floor Disorders, sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 8 months after the study started (first participant enrolled Apr 2023, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Stress urinary incontinence is a common condition in women and is often treated with surgical procedures such as transobturator tape (TOT), tension-free vaginal tape (TVT), and Burch colposuspension. Although these procedures are widely used, there is limited information comparing their short-term anatomical and patient-reported outcomes using imaging techniques.

The aim of this study is to compare the short-term anatomical and subjective outcomes of TOT, TVT, and Burch colposuspension in women with stress urinary incontinence. Transperineal ultrasonography will be used to assess anatomical changes before surgery and during follow-up. Patient-reported outcomes and clinical findings will also be evaluated.

The results of this study may help improve the understanding of surgical outcomes in stress urinary incontinence and support clinical decision-making.

02

Conditions studied

  • Stress Urinary Incontinence in Women
  • Pelvic Floor Disorders

Keywords

  • sui
  • tpus
03

In context

Pelvic Floor Disorders

212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.

This study's enrollment of 80 is above the median of 63 across 148 interventional studies indexed under Pelvic Floor Disorders.

Browse Pelvic Floor Disorders studies →

Lead sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital is the lead sponsor of 38 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients aged 18 years or older
  • Diagnosis of stress urinary incontinence based on clinical evaluation
  • Candidates for surgical treatment with transobturator tape (TOT), tension-free vaginal tape (TVT), or Burch colposuspension
  • Ability to provide written
  • Willingness to participate in the study and comply with follow-up visits

Exclusion criteria

Exclusion Criteria:

  • Mixed or urge-predominant urinary incontinence
  • Previous anti-incontinence or pelvic floor surgery
  • Neurogenic bladder disorders
  • Active urinary tract infection at the time of evaluation
  • Pregnancy or planned pregnancy during the study period
  • Known pelvic
  • Inability to undergo transperineal ultrasonographic evaluation
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (actual)

Study arms

  • Active comparator
    tot

    Participants underwent mid-urethral sling surgery for the treatment of stress urinary incontinence.

    Procedure: Transobturator Tape (TOT) Procedure

  • Active comparator
    tvt

    Participants in this arm underwent tension-free vaginal tape (TVT) surgery for the treatment of stress urinary incontinence.

    Procedure: Tension-Free Vaginal Tape (TVT) Procedure

  • Active comparator
    Burch Colposuspension

    Participants in this arm underwent Burch colposuspension surgery for the treatment of stress urinary incontinence.

    Procedure: Burch Colposuspension Procedure

Interventions

  • ProcedureTransobturator Tape (TOT) Procedure

    Placement of a synthetic tape beneath the mid-urethra via the transobturator route.

    Also known as: tot

  • ProcedureTension-Free Vaginal Tape (TVT) Procedure

    Placement of a synthetic tape beneath the mid-urethra using a retropubic approach.

  • ProcedureBurch Colposuspension Procedure

    Suspension of the anterior vaginal wall to the iliopectineal (Cooper's) ligament using non-absorbable sutures.

06

What researchers measure

Primary outcomes

  1. Change in Urethrovesical and Urethral Angles Assessed by Transperineal Ultrasound

    The primary outcome is the change in urethrovesical and urethral angles measured by transperineal ultrasonography before surgery and at 3 months after surgery.

    Time frame: Baseline (preoperative) and 3 months postoperatively

Secondary outcomes

  1. Subjective Improvement in Stress Urinary Incontinence Symptoms

    Subjective outcomes were assessed using the Urogenital Distress Inventory-Short Form (UDI-6) and the Incontinence Impact Questionnaire-Short Form (IIQ-7). For both scales, scores range from 0 to 100, where higher scores indicate a greater impact of symptoms and worse quality of life.

    Time frame: Baseline and 3 months postoperatively

Other outcomes

  1. Comparison of Anatomical Outcomes Between Surgical Techniques

    Anatomical outcomes assessed by transperineal ultrasonography were compared between the TOT, TVT, and Burch colposuspension groups.

    Time frame: 3 months postoperatively

07

Study locations

1 site
  • Zeynep Kamil Women and Children Diseases Training and Research Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07312617
Lead sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Responsible party
gizem boz izceyhan (doctor, Zeynep Kamil Maternity and Pediatric Research and Training Hospital) — Principal investigator
First posted
Dec 31, 2025
Start date
Apr 1, 2023
Primary completion
Apr 1, 2025
Completion
Apr 1, 2025
Last update
Jan 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion